229 results on '"Tailleux, Anne"'
Search Results
2. Roux-en-Y gastric bypass induces hepatic transcriptomic signatures and plasma metabolite changes indicative of improved cholesterol homeostasis
3. Adipocyte-specific FXR-deficiency protects adipose tissue from oxidative stress and insulin resistance and improves glucose homeostasis
4. Enterohepatic, Gluco-metabolic, and Gut Microbial Characterization of Individuals With Bile Acid Malabsorption
5. Bile acids contribute to the development of non-alcoholic steatohepatitis in mice
6. The hepatic compensatory response to elevated systemic sulfide promotes diabetes
7. NASH-related increases in plasma bile acid levels depend on insulin resistance
8. Endothelial Dysfunction and Pre-Existing Cognitive Disorders in Stroke Patients.
9. Bile acids associate with glucose metabolism, but do not predict conversion from impaired fasting glucose to diabetes
10. Sirt6 deletion in bone marrow-derived cells increases atherosclerosis – Central role of macrophage scavenger receptor 1
11. Corrigendum to “Adipocyte-specific FXR-deficiency protects adipose tissue from oxidative stress and insulin resistance and improves glucose homeostasis” [Mol Metab 69 (2023) 1–13]
12. Hepatic PPARα is critical in the metabolic adaptation to sepsis
13. MPO is partially associated with neutrophil deleterious effect in acute cerebral ischemia
14. Deletion of the nuclear receptor RORα in macrophages does not modify the development of obesity, insulin resistance and NASH
15. Anacetrapib, but not evacetrapib, impairs endothelial function in CETP-transgenic mice in spite of marked HDL-C increase
16. The nuclear receptor FXR inhibits Glucagon-Like Peptide-1 secretion in response to microbiota-derived Short-Chain Fatty Acids
17. Reduction of Atherosclerosis in Apolipoprotein E Knockout Mice by Activation of the Retinoid X Receptor
18. Multi-Omics Data Integration Reveals Sex-Dependent Hippocampal Programming by Maternal High-Fat Diet during Lactation in Adult Mouse Offspring.
19. Analysis of the association of MPO and MMP-9 with stroke severity and outcome: Cohort study
20. Lipid-lowering drugs prevent neurovascular and cognitive consequences of cardiopulmonary bypass
21. Bile acid alterations in nonalcoholic fatty liver disease, obesity, insulin resistance and type 2 diabetes: what do the human studies tell?
22. The Bile Acid Chenodeoxycholic Acid Increases Human Brown Adipose Tissue Activity
23. Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma
24. Targeting the gut microbiota with inulin-type fructans: preclinical demonstration of a novel approach in the management of endothelial dysfunction
25. Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese Subjects
26. Apolipoprotein F is reduced in humans with steatosis and controls plasma triglyceride‐rich lipoprotein metabolism.
27. Screening strategy to generate cell specific recombination: a case report with the RIP-Cre mice
28. Normal HDL–apo AI turnover and cholesterol enrichment of HDL subclasses in New Zealand rabbits with partial nephrectomy
29. Host Glucose Metabolism Mediates T4 and Il-7 Action on Schistosoma mansoni Development
30. Hypothalamic bile acid-TGR5 signaling protects from obesity
31. Bariatric surgery, lipoprotein metabolism and cardiovascular risk
32. The Sirt1 activator SRT3025 provides atheroprotection in Apoe−/− mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression
33. Enterohepatic Takeda G-Protein Coupled Receptor 5 Agonism in Metabolic Dysfunction-Associated Fatty Liver Disease and Related Glucose Dysmetabolism.
34. The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis in mice
35. Cdkn2a/p16Ink4a Regulates Fasting-Induced Hepatic Gluconeogenesis Through the PKA-CREB-PGC1α Pathway
36. Glucose Sensing O-GlcNAcylation Pathway Regulates the Nuclear Bile Acid Receptor Farnesoid X Receptor (FXR)
37. Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
38. WED-458 - Increasing gut microbiota produced secondary bile acids to protect against non-alcoholic steatohepatitis
39. THU-244 - The intestinal immune barrier is associated with bile acid pool modifications in mice suffering from non-alcoholic steatohepatitis
40. Activation of intestinal peroxisome proliferator-activated receptor-α increases high-density lipoprotein production
41. Detrimental Effects of Diet-Induced Obesity on τ Pathology Are Independent of Insulin Resistance in τ Transgenic Mice
42. NMDA receptor dysfunction contributes to impaired brain-derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a Tau transgenic model
43. Murine models to investigate pharmacological compounds acting as ligands of PPARs in dyslipidemia and atherosclerosis
44. Impaired Glucose Homeostasis in a Tau Knock-In Mouse Model.
45. Farnesoid X Receptor Activation in Brain Alters Brown Adipose Tissue Function via the Sympathetic System.
46. Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation?
47. Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-beta particle formation by serum from human apolipoprotein A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transport
48. PS1 - 2. Role of the tumour suppressor CDKN2A/p16INK4a in the development of perivascular adipose tissue
49. Melatonin related compounds inhibit lipid peroxidation during copper or free radical-induced LDL oxidation
50. Deletion of fibroblast activation protein provides atheroprotection.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.